BIOGY(BIOGY)
BIOGY
No analyst ratings available
No analyst price targets available for BIOGY
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $1.68B | $1.87B |
| Low | $1.68B | $1.87B |
| High | $1.68B | $1.87B |
| EBITDA Avg | $606M | $677M |
| Low | $606M | $677M |
| High | $606M | $677M |
| EBIT Avg | $562M | $628M |
| Low | $562M | $628M |
| High | $562M | $628M |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $395M | $459M |
| Low | $395M | $459M |
| High | $395M | $459M |
| EBITDA Avg | $143M | $166M |
| Low | $143M | $166M |
| High | $143M | $166M |
| EBIT Avg | $133M | $154M |
| Low | $133M | $154M |
| High | $133M | $154M |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |